Genetic modifiers of repeat expansion disorders.

DNA synthesis and repair cag repeat genetic modifier repeat expansion somatic DNA expansion somatic instability

Journal

Emerging topics in life sciences
ISSN: 2397-8554
Titre abrégé: Emerg Top Life Sci
Pays: England
ID NLM: 101706399

Informations de publication

Date de publication:
14 Dec 2023
Historique:
received: 19 05 2023
revised: 20 09 2023
accepted: 09 10 2023
pubmed: 20 10 2023
medline: 20 10 2023
entrez: 20 10 2023
Statut: ppublish

Résumé

Repeat expansion disorders (REDs) are monogenic diseases caused by a sequence of repetitive DNA expanding above a pathogenic threshold. A common feature of the REDs is a strong genotype-phenotype correlation in which a major determinant of age at onset (AAO) and disease progression is the length of the inherited repeat tract. Over a disease-gene carrier's life, the length of the repeat can expand in somatic cells, through the process of somatic expansion which is hypothesised to drive disease progression. Despite being monogenic, individual REDs are phenotypically variable, and exploring what genetic modifying factors drive this phenotypic variability has illuminated key pathogenic mechanisms that are common to this group of diseases. Disease phenotypes are affected by the cognate gene in which the expansion is found, the location of the repeat sequence in coding or non-coding regions and by the presence of repeat sequence interruptions. Human genetic data, mouse models and in vitro models have implicated the disease-modifying effect of DNA repair pathways via the mechanisms of somatic mutation of the repeat tract. As such, developing an understanding of these pathways in the context of expanded repeats could lead to future disease-modifying therapies for REDs.

Identifiants

pubmed: 37861103
pii: 233635
doi: 10.1042/ETLS20230015
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

325-337

Informations de copyright

© 2023 The Author(s).

Auteurs

Sangeerthana Rajagopal (S)

UCL Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, U.K.
UK Dementia Research Institute, University College London, London WCC1N 3BG, U.K.

Jasmine Donaldson (J)

UCL Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, U.K.
UK Dementia Research Institute, University College London, London WCC1N 3BG, U.K.

Michael Flower (M)

UCL Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, U.K.
UK Dementia Research Institute, University College London, London WCC1N 3BG, U.K.

Davina J Hensman Moss (DJ)

UCL Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, U.K.
UK Dementia Research Institute, University College London, London WCC1N 3BG, U.K.
St George's University of London, London SW17 0RE, U.K.

Sarah J Tabrizi (SJ)

UCL Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, U.K.
UK Dementia Research Institute, University College London, London WCC1N 3BG, U.K.

Classifications MeSH